About UslAdvertisinglMagazinelNewsletterlContact Usl Instagram

Fire-Based EMS: GlaxoSmithKline Awarded Up to $200M by U.S. to Develop New Antibiotics

05/24/2013
GlaxoSmithKline (GSK) plc and the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS), have agreed to a first of its kind collaboration that will support the development of several antibiotics to fight antibiotic resistance and bioterrorism. This public-private agreement marks the first time that HHS has taken a "portfolio approach" to funding drug development with a private sector company. This unique collaboration provides flexibility to move funding around GSK's antibacterial portfolio, rather than focusing on just one drug candidate and allow medicines to be studied for the potential treatment o...

Already a member of the Fire Engineering Training Network?  If yes, please sign in!

LOGIN TODAY

Why Subscribe?

  Gain Access to:
   
  • Latest Training & Drills
  • New Techniques
  • Technology Advances
 
  • Proven Tactics
  • Research to help reduce injuries & Deaths
  • Insight from the fire service's most experienced
 

      More Information >>